Orca-T
Phase I Trial for Patients With Advanced Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation From an HLA-Mismatched Donor (7/8) With Orca-T
More Information
- Trial Status
- Not yet accepting
- Trial Phase
- Phase 1
- Enrollment
- 24 patients (estimated)
- Sponsors
- Stanford University Cancer Institute (Palo Alto)
- Collaborators
- Orca Biosystems, Inc.
- Tags
- Allogeneic Stem Cell Transplant, T Cell (Allogeneic)
- Trial Type
- Treatment
- Last Update
- 2 weeks ago
- SparkCures ID
- 1981
- NCT Identifier
- NCT06551584
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.